QualityStocksNewsBreaks Archives - Page 573 of 1453

TuesdayOct 26, 2021 2:49 pm

QualityStocksNewsBreaks – Why Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR) Is ‘One to Watch’

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR) is a software-as-a-service (“SaaS”) technology company focused on developing and licensing digital content for the growing global iGaming market. The company’s multi-tenant gateway provides online operators the ability to offer iGaming software solutions to their customers. “Playgon’s proprietary technology provides digital games for online gambling sites and mobile device apps, with the company licensing its mobile live-dealer technology to online gaming operators worldwide. Playgon combines high-definition live streaming dealers with state-of-the-art augmented reality betting to provide the most authentic casino experience, live from Las Vegas. Playgon’s mobile platform features popular table games, all optimized…

TuesdayOct 26, 2021 2:28 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Enters LOI to Acquire Omni Services LLC

RYAH Group (CSE: RYAH) today announced its entry into a non-binding letter of intent (“LOI”) with Omni Services LLC (d/b/a “Omni Medical Services” or “Omni”), a leading physician-owned and operated telehealth, cannabis clinic and certifications company operating in the United States, with respect to the potential acquisition of 100% of the business and assets of Omni. The LOI, if consummated, is expected to combine Omni's clinical research capabilities with the company's IoT monitoring and control devices, and further the company's ability to procure state and federal grants in the United States, which are reserved for the funding of clinical research…

TuesdayOct 26, 2021 1:53 pm

QualityStocksNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Enters Agreement with Aragen Life Sciences to Produce Innovative Drug Candidate

Clearmind Medicine (CSE: CMND) (FSE: CWY0), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, today announced its entry into a development and supply agreement with Aragen Life Sciences Pvt. Ltd for the production of its innovative molecule, 5-Methoxy-2-aminoindane (“MEAI”). Aragen is a global leader in providing discovery, development and manufacturing solutions for life sciences firms under Good Manufacturing Practices. Under the agreement, Aragen will complete a process optimization and synthesis, manufacturing and supply of MEAI to Clearmind. “Aragen is a world-class, life-sciences company with state-of-the-art manufacturing…

TuesdayOct 26, 2021 1:46 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Continued Availability of Replays from 2021 LD Micro Main Event

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, hosted the 2021 LD Micro Main Event, both in-person in Los Angeles and virtually via its Sequire Virtual Events platform. The event marked the first in-person conference for LD Micro in almost two years and brought physical and virtual elements together to form a truly unique experience. Replays from the 139 presenting companies will continue to be available for viewing for three months. Interested parties should visit the event website to access and view the presentations. To view…

TuesdayOct 26, 2021 1:38 pm

QualityStocksNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Enters ROE with Premier Silver Corp.

StraightUp Resources (CSE: ST) (OTCQB: STUPF) today announced its entry into a right of exclusivity agreement (“ROE”) with Premier Silver Corp. (“Premier” or “PSC”). According to the update, the ROE provides that StraightUp and Premier will exclusively negotiate an agreement for a period of 60 days, whereby StraightUp will acquire all of the outstanding shares of Premier from the current shareholders. Premier was formed by a group with a combined 100-plus years of experience in the junior mining industry, raising in excess of $700 million in capital and creating more than $1 billion in shareholder value. PSC, in 2020, concluded…

TuesdayOct 26, 2021 1:28 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces FDA IND Authorization of Potentially Pivotal Study

Cybin (NYSE American: CYBN) (NEO: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has announced that the U.S. Food and Drug Administration (“FDA”) has authorized an Investigational New Drug (“IND”) application to proceed with the company’s sponsored feasibility study. The study focuses on using Kernel’s Flow technology to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics. “The word psychedelic means ‘mind-manifesting,’ but what has been missing is useful ‘mind-imaging’—the ability to dynamically trace the neural correlates of human conscious experience,” said Cybin’s Chief Clinical Officer Dr. Alex Belser. “Conventional neuroimaging just isn’t dynamic enough to study the psychedelic experience…

TuesdayOct 26, 2021 12:38 pm

QualityStocksNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Announces Key Milestone in Building Farm-to-Sale Vertical Model

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that the company is set to take full operational control of the downtown Los Angeles “MDRN Tree” cannabis product dispensary. MDRN Tree is the company’s first in-house end-market consumer-facing retail sales outlet. Beginning in November 2021, NUGS will begin to record sales from the dispensary on its books. “We continue to build a full farm-to-sale vertical model, and MDRN Tree is a big part of that vision,” said Simon Yu, CEO of NUGS. “It’s exciting to watch the pieces come together, and we look forward…

TuesdayOct 26, 2021 12:25 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Expansion of HealthTab Patient Testing in Select Shoppers Drug Mart Locations

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, has launched its HealthTab(TM) platform in various Shoppers Drug Mart(R) pharmacies located throughout British Columbia. This move marks the first time the company’s diabetes screening program has been available in Western Canada. Avricore signed a master agreement with Shoppers Drug Mart Inc. earlier this year. That agreement involved a pilot program that provided patients with access to point-of-care blood screening and health-data management for potential risks for developing diabetes and cardiovascular conditions. Those services were offered through AVCRF’s HealthTab-integrated…

TuesdayOct 26, 2021 12:10 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at Upcoming Pain Therapeutics Summit

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, has announced that it will present at the 15th Annual Pain Therapeutics Summit. The event is slated to take place on Nov. 1-3, 2021, with Tryp’s presentation scheduled to begin at 11:15 a.m. Central Time / 12:15 p.m. Eastern Time on Nov. 1. Chairman and CEO Greg McKee will provide an overview of the company followed by a live question-and-answer session with emphasis on the chronic pain indications that Tryp is pursuing including fibromyalgia, phantom limb pain, and complex regional…

TuesdayOct 26, 2021 12:01 pm

QualityStocksNewsBreaks – Delic Holdings Inc.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Lab Facility Enters Partnership with GT Research for Comarketing Efforts

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has inked a comarketing agreement focused on computational genetic analysis and trait optimization for cannabis and psychedelics. The agreement was signed through Delic Labs, which inked the deal with GTR Research Inc. (“GTR”). GTR is leading out in applying cutting-edge computational and biotech to cannabis and psychedelics. According to the company, Delic Labs will provide genetic analysis of psychedelic mushrooms and cannabis to producers in Canada; the analysis will include sample preparation, DNA extraction, whole-genome sequencing, computational analysis and reporting, as…

Site Search

Company Search

Category: QualityStocksNewsBreaks